Pictet Asset Management (UK)’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $84.7M | Buy |
1,085,793
+269,589
| +33% | +$21M | 0.09% | 253 |
|
|
2021
Q1 | $77.2M | Buy |
816,204
+50,938
| +7% | +$4.82M | 0.09% | 246 |
|
|
2020
Q4 | $93.2M | Sell |
765,266
-4,925
| -0.6% | -$600K | 0.12% | 208 |
|
|
2020
Q3 | $67.3M | Sell |
770,191
-372,990
| -33% | -$32.6M | 0.11% | 224 |
|
|
2020
Q2 | $73.8M | Buy |
1,143,181
+585,406
| +105% | +$37.8M | 0.13% | 203 |
|
|
2020
Q1 | $24.9M | Sell |
557,775
-25,153
| -4% | -$1.12M | 0.05% | 329 |
|
|
2019
Q4 | $36.3M | Buy |
582,928
+367,891
| +171% | +$22.9M | 0.06% | 324 |
|
|
2019
Q3 | $8.09M | Buy |
+215,037
| New | +$8.09M | 0.02% | 565 |
|